NDC 0061-1088 - Optimmune Ophthalmic

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 0061-1088
Package NDCs from labels: 0061-1088-01
Manufacturer: Merck Sharp & Dohme Corp.
Effective date: 2026-01-16
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Optimmune ® (0.2% Cyclosporine, USP) Ophthalmic Ointment	Merck Sharp & Dohme Corp.	2026-01-16	PRESCRIPTION ANIMAL DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0061-1088-01	Optimmune Ophthalmic	3.5 g in 1 TUBE	OINTMENT	3.5		10
0061-1088-01	Optimmune Ophthalmic	1 in 1 CARTON	OINTMENT	1		10

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0061-1088	OPTIMMUNE OPHTHALMIC (CYCLOSPORINE) OINTMENT [MERCK SHARP & DOHME CORP.]	8	2 package rows	20241120_8ee9c677-d86c-4f2f-9eec-6998f4394ae1.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Cyclosporine	ACTIVE INGREDIENT	83HN0GTJ6D	OPTIMMUNE (CYCLOSPORINE) OINTMENT [SCHERING CORPORATION]	2
Cyclosporine	ACTIVE MOIETY	83HN0GTJ6D	OPTIMMUNE (CYCLOSPORINE) OINTMENT [SCHERING CORPORATION]	2
Corn Oil	INACTIVE INGREDIENT	8470G57WFM	OPTIMMUNE (CYCLOSPORINE) OINTMENT [SCHERING CORPORATION]	2
Lanolin Alcohols	INACTIVE INGREDIENT	884C3FA9HE	OPTIMMUNE (CYCLOSPORINE) OINTMENT [SCHERING CORPORATION]	2
Paraffin	INACTIVE INGREDIENT	I9O0E3H2ZE	OPTIMMUNE (CYCLOSPORINE) OINTMENT [SCHERING CORPORATION]	2
Petrolatum	INACTIVE INGREDIENT	4T6H12BN9U	OPTIMMUNE (CYCLOSPORINE) OINTMENT [SCHERING CORPORATION]	2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 26 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cyclosporine	CYCLOSPORINE	Dr. Reddy's Laboratories Inc	64ec430a-e930-145c-e766-13fb49b64644	2024-06-03	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: 83HN0GTJ6D
RESTASIS	CYCLOSPORINE	A-S Medication Solutions	ee57c1c0-2fcd-4628-8e33-4e0a9dadcb03	2024-05-24	Warnings, Adverse reactions	Exact identifier unii: 83HN0GTJ6D
Cyclosporine	CYCLOSPORINE	American Health Packaging	a8e29b54-e4ab-4bb9-ab6c-e4414a3f025b	2024-05-13	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: 83HN0GTJ6D
Cyclosporine Modified	CYCLOSPORINE	Teva Pharmaceuticals USA, Inc.	2de1e8b1-625f-43ce-a1d5-d543be208b11	2024-04-01	Boxed warning, Warnings, Adverse reactions	Exact identifier unii: 83HN0GTJ6D
Cyclosporine	CYCLOSPORINE	Teva Pharmaceuticals, Inc.	cc64c1e3-19f5-4bf6-a08d-a9725004c97f	2024-03-01	Warnings, Adverse reactions	Exact identifier unii: 83HN0GTJ6D
Cyclosporine	CYCLOSPORINE	Mylan Pharmaceuticals Inc.	da3fa070-b512-4568-871a-dc8d5a949d13	2022-01-20	Warnings, Adverse reactions	Exact identifier unii: 83HN0GTJ6D

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.